OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 200,131 shares at $0.73 ($147K) on 2024-09-17, disclosed to the SEC on 2024-09-18.
Open-market sale of $147k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.74 | 63,100 | $47K | 31.8% |
| 2 | $0.73 | 111,400 | $81K | 55.4% |
| 3 | $0.73 | 25,631 | $19K | 12.8% |
| Total | $0.73 avg | 200,131 | $147K | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| ELVN | SELL | 2024-05-20 | $22.9M | — | Filing → |